Table 2 List of antidepressants examined in studies (N=29)
NbN glossary | Medications | Studies | |
|---|---|---|---|
n | % | ||
SERT | SSRI (general) | 4 | 13.79 |
fluoxetine | 8 | 27.59 | |
paroxetine | 2 | 6.90 | |
sertraline | 5 | 17.24 | |
escitalopram | 3 | 10.34 | |
citalopram | 3 | 10.34 | |
fluvoxamine | 1 | 3.45 | |
SERT and NET | SNRI (general) | 1 | 3.45 |
venlafaxine | 3 | 10.34 | |
duloxetine | 1 | 3.45 | |
amoxapine | 1 | 3.45 | |
clomipramine | 1 | 3.45 | |
Melatonin, serotonin agonist and antagonist | agomelatine | 1 | 3.45 |
Norepinephrine MM | mianserin | 1 | 3.45 |
Histamine, norepinephrine, serotonin antagonist | mirtazapine | 1 | 3.45 |
- | tricyclic (general) | 1 | 3.45 |
MM; SERT and NET, receptor antagonist (5-HT2) | amitriptyline | 1 | 3.45 |
NET, DAT, norepinephrine, dopamine releaser | bupropion | 1 | 3.45 |
serotonin antagonist and agonist | nefazodone | 1 | 3.45 |
- | not specified antidepressants | 6 | 20.69 |